Autolus Therapeutics (AUTL) Earnings
|
Expand Research on AUTL
| Next EPS Date | 7/30/26 | EPS Growth Rate | -38.9% |
|---|---|---|---|
| Average EPS % Beat Rate | -5.6% | Revenue Growth Rate | +45.7% |
| Average % Move 1-Wk after EPS | -5.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/30/26  |
Q226 | N/A | -$0.25 | N/A | N/A | $30.46M | = | N/A | N/A | ||
| 5/14/26 | Q126 | -$0.27 | -$0.25 | -$0.02 | $26.22M | $26.27M | = |  | | Details | |
| 5/5/26 |
Q126 | N/A | -$0.25 | N/A | N/A | $26.27M | = | N/A | N/A | ||
| 5/4/26 |
Q126 | N/A | -$0.25 | N/A | N/A | $26.27M | = | N/A | N/A | ||
| 5/1/26 |
Q126 | N/A | -$0.25 | N/A | N/A | $26.27M | = | N/A | N/A | ||
| 4/30/26 |
Q126 | N/A | -$0.25 | N/A | N/A | $26.27M | = | N/A | N/A | ||
| 3/27/26 | Q425 | -$0.34 | -$0.25 | -$0.09 | $24.29M | $24.89M | = | | | Details | |
| 3/17/26 |
Q425 | N/A | -$0.25 | N/A | N/A | $24.89M | N/A | N/A | N/A |
